Behind the scenes of innovation
EMBL Grenoble technology teams provide a sneak peek into their latest collaborative project in structural biology services: the complete automation of an integral step in X-ray crystallography.
EMBLetc2023
Getting closer to stopping toxoplasmosis infection
Recent studies supported by EMBL Grenoble’s expertise in structural biology research and scientific services have identified Altiratinib as a potential drug to stop toxoplasmosis infection and opened up treatment options against malaria.
SCIENCE & TECHNOLOGY2022
sciencescience-technology
Two in one: combining MASSIF-1 and CrystalDirect
Researchers and engineers have integrated a CrystalDirect harvester into the fully automated beamline MASSIF-1, a unique combination of structural biology technologies that is now open to external academic users.
LAB MATTERSSCIENCE & TECHNOLOGY2022
lab-mattersscience-technology
MASSIF-1 beamline in Grenoble supports COVID-19 drug discovery
MASSIF-1, run jointly by EMBL Grenoble and the ESRF, is a beamline for macromolecular crystallography. It is used by the research community to study the 3D structure of proteins, which is important for drug development.
LAB MATTERSSCIENCE & TECHNOLOGY2021
lab-mattersscience-technology
Upgraded beamlines at EMBL Grenoble unveiled
The beamlines run jointly by EMBL Grenoble and the ESRF reopen today, unveiling significant upgrades that exploit the brand new fourth generation ESRF synchrotron source.
EMBL ANNOUNCEMENTS2020
embl-announcementsscience
MASSIFly efficient
MASSIF-1 processes its 10,000th crystal, less than one year after the beamline became operational.
SCIENCE & TECHNOLOGY2015
sciencescience-technology
No results found